Moxetumomab Pasudotox-tdfk and Zevalin In-111
Determining the interaction of Moxetumomab Pasudotox-tdfk and Zevalin In-111 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Zevalin In-111 (Intravenous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab Pasudotox-tdfk-Zevalin Y-90
- Moxetumomab Pasudotox-tdfk-Zflex
- Moxetumomab Pasudotox-tdfk-Zgesic
- Moxetumomab Pasudotox-tdfk-Ziac
- Moxetumomab Pasudotox-tdfk-Ziagen
- Moxetumomab Pasudotox-tdfk-Ziagen (Abacavir Oral Solution)
- Zevalin In-111-Moxetumomab pasudotox-tdfk Intravenous
- Zevalin In-111-Moxifloxacin
- Zevalin In-111-Moxifloxacin (Systemic)
- Zevalin In-111-Moxifloxacin Hydrochloride
- Zevalin In-111-Moxifloxacin Injection
- Zevalin In-111-Moxifloxacin Intravenous